cAMP accumulation

MR Marla Rivera-Oliver
EM Estefanía Moreno
Yocasta Álvarez-Bagnarol
CA Christian Ayala-Santiago
NC Nicole Cruz-Reyes
GM Gian Carlo Molina-Castro
SC Stefan Clemens
EC Enric I. Canela
SF Sergi Ferré
VC Vicent Casadó
MD Manuel Díaz-Ríos
request Request a Protocol
ask Ask a question
Favorite

Homogeneous time-resolved fluorescence energy transfer (HTRF) assays were performed using the Lance Ultra cAMP kit (PerkinElmer, Waltham, Massachusetts, US), based on competitive displacement of an europium chelate-labelled cAMP tracer bound to a specific antibody conjugated to acceptor beads. We first established the optimal cell density for an appropriate fluorescent signal. This was done by measuring the TR-FRET signal determined as a function of forskolin concentration using different cell densities. Forskolin dose-response curves were related to the cAMP standard curve in order to establish which cell density provides a response that covers most of the dynamic range of the cAMP standard curve. Cells were not treated or treated with vehicle or 4 μm of the indicated TAT-fused TM peptides for 4 h at 37°C in an atmosphere of 5% CO2. Cells were then grown (1,000 cells/well in white ProxiPlate 384-well microplates, PerkinElmer) in medium containing 50 μM zardaverine, pretreated at 25°C for 15 min with vehicle or the indicated receptor antagonist, stimulated with agonists for 10 min before adding 20 μM forskolin or vehicle and incubated for an additional 15-min period. Fluorescence at 665 nm was analyzed on a PHERAstar Flagship microplate reader equipped with an HTRF optical module (BMG Lab technologies, Offenburg, Germany).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A